Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Purpura, Thrombotic Thrombocytopenic | 10 | 2024 | 131 | 3.460 |
Why?
|
Thrombotic Microangiopathies | 7 | 2023 | 124 | 2.740 |
Why?
|
Platelet Transfusion | 5 | 2023 | 301 | 2.310 |
Why?
|
Isoantibodies | 5 | 2019 | 681 | 1.670 |
Why?
|
HLA Antigens | 6 | 2019 | 1336 | 1.500 |
Why?
|
Thrombocytopenia | 6 | 2020 | 1181 | 1.370 |
Why?
|
Blood Transfusion | 5 | 2023 | 1309 | 1.340 |
Why?
|
Erythrocytes, Abnormal | 2 | 2023 | 121 | 1.320 |
Why?
|
Plasma Exchange | 6 | 2024 | 159 | 1.160 |
Why?
|
Blood Component Transfusion | 2 | 2024 | 141 | 0.980 |
Why?
|
Hematologic Agents | 1 | 2024 | 39 | 0.910 |
Why?
|
ADAM Proteins | 3 | 2024 | 243 | 0.720 |
Why?
|
Blood Platelets | 4 | 2023 | 2479 | 0.690 |
Why?
|
Hematologic Diseases | 1 | 2023 | 498 | 0.650 |
Why?
|
Anemia, Hemolytic, Autoimmune | 2 | 2008 | 147 | 0.540 |
Why?
|
Gerstmann Syndrome | 1 | 2016 | 4 | 0.540 |
Why?
|
Acute Lung Injury | 2 | 2012 | 378 | 0.540 |
Why?
|
Platelet Count | 4 | 2023 | 787 | 0.510 |
Why?
|
Cytapheresis | 1 | 2015 | 8 | 0.500 |
Why?
|
Blood Donors | 3 | 2019 | 344 | 0.480 |
Why?
|
Middle Cerebral Artery | 1 | 2016 | 273 | 0.470 |
Why?
|
Spleen | 1 | 2020 | 2294 | 0.460 |
Why?
|
Polycythemia | 1 | 2015 | 124 | 0.460 |
Why?
|
Hematopoietic Stem Cell Mobilization | 1 | 2015 | 225 | 0.450 |
Why?
|
Blood Cells | 1 | 2016 | 309 | 0.450 |
Why?
|
Erythrocytes | 2 | 2023 | 2421 | 0.440 |
Why?
|
Blood Component Removal | 1 | 2014 | 132 | 0.430 |
Why?
|
Thrombopoietin | 2 | 2019 | 226 | 0.410 |
Why?
|
Infarction, Middle Cerebral Artery | 1 | 2016 | 487 | 0.410 |
Why?
|
Paraproteinemias | 1 | 2015 | 252 | 0.400 |
Why?
|
Fetomaternal Transfusion | 1 | 2012 | 10 | 0.400 |
Why?
|
Hematopoietic Stem Cells | 2 | 2015 | 3408 | 0.400 |
Why?
|
Receptors, Thrombopoietin | 1 | 2013 | 159 | 0.400 |
Why?
|
Cryoglobulins | 2 | 2008 | 58 | 0.390 |
Why?
|
Receptors, LDL | 3 | 2000 | 492 | 0.370 |
Why?
|
Intensive Care Units | 1 | 2024 | 3800 | 0.360 |
Why?
|
Erythropoietin | 1 | 2015 | 718 | 0.350 |
Why?
|
Postoperative Hemorrhage | 1 | 2014 | 420 | 0.350 |
Why?
|
Autoantibodies | 4 | 2024 | 2126 | 0.340 |
Why?
|
Wounds and Injuries | 1 | 2023 | 2517 | 0.340 |
Why?
|
Activated Protein C Resistance | 1 | 2008 | 18 | 0.310 |
Why?
|
Donor Selection | 1 | 2011 | 240 | 0.310 |
Why?
|
CCAAT-Enhancer-Binding Proteins | 2 | 2000 | 288 | 0.300 |
Why?
|
Microspheres | 1 | 2011 | 789 | 0.290 |
Why?
|
Anemia, Sickle Cell | 1 | 2016 | 1065 | 0.290 |
Why?
|
International Normalized Ratio | 2 | 2024 | 382 | 0.270 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2023 | 9081 | 0.270 |
Why?
|
Hemolysis | 1 | 2008 | 417 | 0.260 |
Why?
|
ABO Blood-Group System | 1 | 2008 | 381 | 0.250 |
Why?
|
Antigen-Presenting Cells | 1 | 2008 | 962 | 0.240 |
Why?
|
Recombinant Proteins | 2 | 2024 | 6512 | 0.230 |
Why?
|
Kidney Diseases | 1 | 2015 | 2100 | 0.230 |
Why?
|
Severity of Illness Index | 4 | 2020 | 15955 | 0.230 |
Why?
|
Leukocytes | 1 | 2012 | 2034 | 0.220 |
Why?
|
Humans | 58 | 2024 | 768887 | 0.220 |
Why?
|
Immunoglobulin M | 1 | 2008 | 1528 | 0.220 |
Why?
|
Encephalitis, Herpes Simplex | 1 | 2003 | 65 | 0.210 |
Why?
|
Antigen Presentation | 1 | 2008 | 1252 | 0.210 |
Why?
|
Antigens | 1 | 2008 | 1444 | 0.200 |
Why?
|
Critical Care | 3 | 2024 | 2715 | 0.200 |
Why?
|
Antigen-Antibody Complex | 1 | 2024 | 513 | 0.200 |
Why?
|
Purpura, Thrombocytopenic, Idiopathic | 2 | 2019 | 246 | 0.200 |
Why?
|
Cell Shape | 1 | 2023 | 371 | 0.200 |
Why?
|
Clinical Laboratory Techniques | 4 | 2014 | 749 | 0.190 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2008 | 1363 | 0.190 |
Why?
|
Flow Cytometry | 1 | 2012 | 5905 | 0.180 |
Why?
|
Plasma | 1 | 2024 | 585 | 0.180 |
Why?
|
Sterols | 2 | 1998 | 64 | 0.180 |
Why?
|
Disseminated Intravascular Coagulation | 1 | 2020 | 187 | 0.170 |
Why?
|
Splenomegaly | 1 | 2020 | 192 | 0.170 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2024 | 667 | 0.170 |
Why?
|
Plateletpheresis | 1 | 2019 | 38 | 0.170 |
Why?
|
Anemia | 2 | 2010 | 1516 | 0.160 |
Why?
|
Tacrolimus | 1 | 2023 | 750 | 0.160 |
Why?
|
Infertility, Male | 1 | 2002 | 398 | 0.160 |
Why?
|
Blood Grouping and Crossmatching | 1 | 2019 | 99 | 0.160 |
Why?
|
Resuscitation | 1 | 2023 | 679 | 0.150 |
Why?
|
Hemostatics | 1 | 2020 | 246 | 0.150 |
Why?
|
Histocompatibility | 1 | 2019 | 321 | 0.150 |
Why?
|
Female | 27 | 2024 | 397464 | 0.150 |
Why?
|
Herpesvirus 1, Human | 1 | 2003 | 744 | 0.150 |
Why?
|
Male | 26 | 2024 | 365249 | 0.150 |
Why?
|
Hypertriglyceridemia | 1 | 2020 | 293 | 0.140 |
Why?
|
Pathology, Clinical | 2 | 2014 | 377 | 0.140 |
Why?
|
Antifibrinolytic Agents | 1 | 2020 | 289 | 0.140 |
Why?
|
Histocompatibility Testing | 1 | 2019 | 716 | 0.140 |
Why?
|
Lymphocyte Activation | 1 | 2008 | 5505 | 0.140 |
Why?
|
Cord Blood Stem Cell Transplantation | 1 | 2019 | 305 | 0.140 |
Why?
|
Lymphopenia | 1 | 2019 | 299 | 0.140 |
Why?
|
Middle Aged | 19 | 2024 | 223740 | 0.130 |
Why?
|
Infertility, Female | 1 | 2002 | 764 | 0.130 |
Why?
|
Diagnosis, Differential | 6 | 2016 | 13020 | 0.130 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2008 | 2171 | 0.130 |
Why?
|
Circulatory Arrest, Deep Hypothermia Induced | 1 | 2015 | 82 | 0.120 |
Why?
|
Hematologic Tests | 1 | 2016 | 239 | 0.120 |
Why?
|
Prognosis | 4 | 2023 | 30044 | 0.120 |
Why?
|
Speech Disorders | 1 | 2016 | 180 | 0.120 |
Why?
|
Aged | 15 | 2024 | 171790 | 0.120 |
Why?
|
Endarterectomy | 1 | 2015 | 196 | 0.120 |
Why?
|
Paracentesis | 1 | 2015 | 99 | 0.120 |
Why?
|
Leukemia, T-Cell | 1 | 1994 | 102 | 0.120 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2008 | 4651 | 0.120 |
Why?
|
Mitogens | 1 | 1994 | 229 | 0.120 |
Why?
|
Retrospective Studies | 9 | 2024 | 81892 | 0.110 |
Why?
|
Treatment Failure | 1 | 2020 | 2663 | 0.110 |
Why?
|
Benzylamines | 1 | 2015 | 251 | 0.110 |
Why?
|
Adult | 18 | 2024 | 223818 | 0.110 |
Why?
|
Urticaria | 1 | 2015 | 151 | 0.110 |
Why?
|
Heterocyclic Compounds | 1 | 2015 | 245 | 0.110 |
Why?
|
Pancreatitis | 1 | 2020 | 1087 | 0.110 |
Why?
|
Antibodies | 3 | 2012 | 2422 | 0.110 |
Why?
|
IgA Deficiency | 1 | 2013 | 39 | 0.110 |
Why?
|
Costs and Cost Analysis | 1 | 2019 | 1669 | 0.110 |
Why?
|
Heparin | 1 | 2020 | 1636 | 0.110 |
Why?
|
Immunity | 1 | 2019 | 1003 | 0.110 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 2023 | 5716 | 0.100 |
Why?
|
Complement System Proteins | 2 | 2023 | 738 | 0.100 |
Why?
|
Electronic Mail | 1 | 2014 | 215 | 0.100 |
Why?
|
Polyneuropathies | 1 | 2014 | 139 | 0.100 |
Why?
|
Tetradecanoylphorbol Acetate | 3 | 2000 | 826 | 0.100 |
Why?
|
Paraneoplastic Syndromes | 1 | 2014 | 154 | 0.100 |
Why?
|
Blood Safety | 1 | 2012 | 16 | 0.100 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2015 | 631 | 0.100 |
Why?
|
Rosette Formation | 1 | 2012 | 152 | 0.100 |
Why?
|
Albumins | 1 | 2015 | 577 | 0.100 |
Why?
|
Antigens, CD34 | 1 | 2014 | 656 | 0.100 |
Why?
|
Rh Isoimmunization | 1 | 2012 | 23 | 0.100 |
Why?
|
Drug Evaluation | 1 | 2013 | 642 | 0.100 |
Why?
|
Rho(D) Immune Globulin | 1 | 2012 | 34 | 0.100 |
Why?
|
Benzoates | 1 | 2013 | 213 | 0.100 |
Why?
|
Hydrazines | 1 | 2013 | 223 | 0.100 |
Why?
|
Thrombopoiesis | 1 | 2013 | 166 | 0.100 |
Why?
|
Antiphospholipid Syndrome | 1 | 2013 | 167 | 0.100 |
Why?
|
Rh-Hr Blood-Group System | 1 | 2012 | 64 | 0.100 |
Why?
|
Cold Temperature | 1 | 2015 | 791 | 0.090 |
Why?
|
Bone Marrow Diseases | 1 | 2013 | 234 | 0.090 |
Why?
|
Acids | 1 | 2012 | 125 | 0.090 |
Why?
|
Prothrombin Time | 2 | 2008 | 117 | 0.090 |
Why?
|
Leukocyte Count | 1 | 2015 | 1609 | 0.090 |
Why?
|
Cohort Studies | 6 | 2020 | 41800 | 0.090 |
Why?
|
Chromosome Aberrations | 2 | 1994 | 1780 | 0.090 |
Why?
|
Immunosuppressive Agents | 1 | 2023 | 4207 | 0.090 |
Why?
|
Nerve Fibers | 1 | 2014 | 709 | 0.090 |
Why?
|
Fetal Blood | 2 | 2019 | 1360 | 0.090 |
Why?
|
Solubility | 1 | 2012 | 1087 | 0.090 |
Why?
|
Hemophilia A | 1 | 2013 | 359 | 0.080 |
Why?
|
Receptors, Fc | 1 | 2013 | 538 | 0.080 |
Why?
|
Immunologic Factors | 1 | 2019 | 1597 | 0.080 |
Why?
|
Cystadenocarcinoma, Serous | 1 | 1994 | 480 | 0.080 |
Why?
|
Fatal Outcome | 1 | 2014 | 1836 | 0.080 |
Why?
|
Thromboembolism | 1 | 2016 | 1004 | 0.080 |
Why?
|
Fetal Hemoglobin | 1 | 2012 | 346 | 0.080 |
Why?
|
Disease Management | 1 | 2020 | 2537 | 0.080 |
Why?
|
Sterol Regulatory Element Binding Protein 1 | 2 | 2000 | 136 | 0.080 |
Why?
|
Erythrocyte Aggregation | 1 | 2008 | 35 | 0.080 |
Why?
|
Syndrome | 1 | 2015 | 3274 | 0.080 |
Why?
|
Immunoglobulin Idiotypes | 1 | 1988 | 201 | 0.080 |
Why?
|
Acute Disease | 3 | 2020 | 7245 | 0.080 |
Why?
|
Antibodies, Antiphospholipid | 1 | 2008 | 72 | 0.080 |
Why?
|
Nuclear Proteins | 2 | 2000 | 5803 | 0.080 |
Why?
|
Pathology Department, Hospital | 1 | 2007 | 10 | 0.070 |
Why?
|
Headache | 1 | 2016 | 1263 | 0.070 |
Why?
|
Genes, Immunoglobulin | 1 | 1988 | 286 | 0.070 |
Why?
|
Retinal Diseases | 1 | 2014 | 710 | 0.070 |
Why?
|
Jurkat Cells | 2 | 2000 | 739 | 0.070 |
Why?
|
Staining and Labeling | 1 | 2012 | 1081 | 0.070 |
Why?
|
Immunoglobulin Variable Region | 1 | 1988 | 420 | 0.070 |
Why?
|
Heating | 1 | 2008 | 104 | 0.070 |
Why?
|
Treatment Outcome | 5 | 2024 | 65485 | 0.070 |
Why?
|
Recombinant Fusion Proteins | 2 | 2013 | 3744 | 0.070 |
Why?
|
Academic Medical Centers | 2 | 2014 | 2784 | 0.070 |
Why?
|
Lupus Nephritis | 1 | 2010 | 327 | 0.070 |
Why?
|
Ionomycin | 2 | 1998 | 110 | 0.070 |
Why?
|
Salvage Therapy | 1 | 2013 | 1277 | 0.070 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2019 | 4413 | 0.070 |
Why?
|
Wiskott-Aldrich Syndrome Protein, Neuronal | 1 | 2006 | 88 | 0.070 |
Why?
|
Antibody Specificity | 1 | 2008 | 1065 | 0.070 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 3814 | 0.070 |
Why?
|
Insulin | 1 | 2020 | 6610 | 0.060 |
Why?
|
Length of Stay | 2 | 2020 | 6525 | 0.060 |
Why?
|
Immunoglobulin Heavy Chains | 1 | 1988 | 648 | 0.060 |
Why?
|
Rabbits | 1 | 2012 | 4774 | 0.060 |
Why?
|
DNA-Binding Proteins | 2 | 2000 | 9618 | 0.060 |
Why?
|
Liability, Legal | 1 | 2007 | 209 | 0.060 |
Why?
|
Heart Valve Diseases | 1 | 2013 | 1030 | 0.060 |
Why?
|
Reproducibility of Results | 1 | 2023 | 20244 | 0.060 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2020 | 3626 | 0.060 |
Why?
|
Waldenstrom Macroglobulinemia | 1 | 2014 | 1077 | 0.060 |
Why?
|
Consensus | 1 | 2014 | 3214 | 0.060 |
Why?
|
Immunization | 1 | 2008 | 1219 | 0.060 |
Why?
|
Time Factors | 2 | 2024 | 40266 | 0.060 |
Why?
|
Patient Selection | 2 | 2013 | 4265 | 0.060 |
Why?
|
Transcription Factors | 2 | 2000 | 12174 | 0.050 |
Why?
|
Aortic Valve | 1 | 2013 | 1969 | 0.050 |
Why?
|
Retina | 1 | 2014 | 2661 | 0.050 |
Why?
|
Pyrazoles | 1 | 2013 | 2029 | 0.050 |
Why?
|
Ovulation Detection | 1 | 2002 | 5 | 0.050 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2013 | 1568 | 0.050 |
Why?
|
Colombia | 1 | 2003 | 287 | 0.050 |
Why?
|
Tubulin | 1 | 2006 | 695 | 0.050 |
Why?
|
Base Sequence | 4 | 2000 | 12430 | 0.050 |
Why?
|
Kidney | 2 | 2023 | 7057 | 0.050 |
Why?
|
Pulmonary Embolism | 1 | 2015 | 2598 | 0.050 |
Why?
|
Spinal Puncture | 1 | 2003 | 286 | 0.050 |
Why?
|
Temperature | 1 | 2008 | 2235 | 0.050 |
Why?
|
Mycophenolic Acid | 1 | 2023 | 348 | 0.050 |
Why?
|
Models, Biological | 1 | 2017 | 9499 | 0.040 |
Why?
|
Ovarian Neoplasms | 2 | 1994 | 4919 | 0.040 |
Why?
|
Skin | 1 | 2014 | 4507 | 0.040 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 2010 | 1252 | 0.040 |
Why?
|
Protein Synthesis Inhibitors | 1 | 2000 | 188 | 0.040 |
Why?
|
Cycloheximide | 1 | 2000 | 341 | 0.040 |
Why?
|
Risk | 1 | 2012 | 9621 | 0.040 |
Why?
|
Blood Vessel Prosthesis Implantation | 1 | 2010 | 1459 | 0.040 |
Why?
|
Vaccines | 1 | 2008 | 842 | 0.040 |
Why?
|
Semen | 1 | 2002 | 349 | 0.040 |
Why?
|
Pregnancy | 3 | 2012 | 30175 | 0.040 |
Why?
|
DNA Probes | 1 | 2000 | 543 | 0.040 |
Why?
|
Genes, Regulator | 1 | 2000 | 373 | 0.040 |
Why?
|
von Willebrand Factor | 1 | 2023 | 680 | 0.040 |
Why?
|
Germ Cells | 1 | 2023 | 644 | 0.040 |
Why?
|
Sensitivity and Specificity | 2 | 2012 | 14751 | 0.040 |
Why?
|
Actins | 1 | 2006 | 2065 | 0.040 |
Why?
|
Chloramphenicol O-Acetyltransferase | 1 | 1998 | 221 | 0.040 |
Why?
|
Living Donors | 1 | 2023 | 649 | 0.040 |
Why?
|
Ionophores | 1 | 1998 | 108 | 0.040 |
Why?
|
Renal Replacement Therapy | 1 | 2020 | 282 | 0.040 |
Why?
|
Medical History Taking | 1 | 2002 | 779 | 0.040 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 1994 | 8664 | 0.040 |
Why?
|
Sterol Regulatory Element Binding Protein 2 | 1 | 1998 | 58 | 0.040 |
Why?
|
Steroids | 1 | 2023 | 938 | 0.040 |
Why?
|
Promoter Regions, Genetic | 2 | 2000 | 5801 | 0.040 |
Why?
|
Travel | 1 | 2003 | 805 | 0.040 |
Why?
|
Cytomegalovirus Infections | 1 | 2003 | 839 | 0.030 |
Why?
|
Endothelium, Vascular | 1 | 2009 | 4428 | 0.030 |
Why?
|
Tumor Cells, Cultured | 2 | 1994 | 6131 | 0.030 |
Why?
|
DNA, Viral | 1 | 2003 | 2205 | 0.030 |
Why?
|
Immunoglobulin G | 1 | 2008 | 4568 | 0.030 |
Why?
|
Vasodilator Agents | 1 | 2020 | 990 | 0.030 |
Why?
|
Genes, Reporter | 1 | 2000 | 1524 | 0.030 |
Why?
|
Physical Examination | 1 | 2002 | 1262 | 0.030 |
Why?
|
Fever | 1 | 2003 | 1620 | 0.030 |
Why?
|
Sequence Deletion | 1 | 2000 | 1498 | 0.030 |
Why?
|
Temporal Lobe | 1 | 2003 | 1728 | 0.030 |
Why?
|
Transfection | 2 | 2006 | 5763 | 0.030 |
Why?
|
Karyotyping | 2 | 1994 | 1177 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2012 | 10397 | 0.030 |
Why?
|
Early Diagnosis | 1 | 2020 | 1195 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 2 | 2016 | 20776 | 0.030 |
Why?
|
Germ-Line Mutation | 1 | 2023 | 1887 | 0.030 |
Why?
|
Chromosome Banding | 1 | 1994 | 261 | 0.030 |
Why?
|
Molecular Sequence Data | 3 | 2000 | 17629 | 0.030 |
Why?
|
Polymerase Chain Reaction | 1 | 2003 | 6085 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 2 | 2016 | 36861 | 0.030 |
Why?
|
Physician Executives | 1 | 2014 | 140 | 0.030 |
Why?
|
Work | 1 | 2014 | 195 | 0.030 |
Why?
|
Ascites | 1 | 2015 | 338 | 0.030 |
Why?
|
Laboratories, Hospital | 1 | 2014 | 192 | 0.030 |
Why?
|
Triglycerides | 1 | 2020 | 2464 | 0.030 |
Why?
|
Periodicity | 1 | 2014 | 348 | 0.030 |
Why?
|
Fundus Oculi | 1 | 2014 | 560 | 0.030 |
Why?
|
Immunotherapy | 1 | 2008 | 4755 | 0.020 |
Why?
|
Electroretinography | 1 | 2014 | 524 | 0.020 |
Why?
|
Equipment Design | 1 | 2019 | 3529 | 0.020 |
Why?
|
Risk Factors | 3 | 2015 | 74971 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2020 | 6320 | 0.020 |
Why?
|
RNA, Messenger | 2 | 1998 | 12809 | 0.020 |
Why?
|
Northern Ireland | 1 | 2010 | 37 | 0.020 |
Why?
|
Seizures | 1 | 2003 | 3000 | 0.020 |
Why?
|
Graft Rejection | 1 | 2023 | 4492 | 0.020 |
Why?
|
Animals | 4 | 2012 | 169408 | 0.020 |
Why?
|
Pilot Projects | 1 | 2023 | 8742 | 0.020 |
Why?
|
Hospitals, General | 1 | 2014 | 810 | 0.020 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2023 | 3116 | 0.020 |
Why?
|
Respiration, Artificial | 1 | 2020 | 2724 | 0.020 |
Why?
|
Young Adult | 1 | 2016 | 60110 | 0.020 |
Why?
|
Blood Loss, Surgical | 1 | 2013 | 643 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2019 | 6856 | 0.020 |
Why?
|
Gene Rearrangement, B-Lymphocyte | 1 | 1988 | 111 | 0.020 |
Why?
|
Confusion | 1 | 2010 | 278 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2019 | 6546 | 0.020 |
Why?
|
Fluorescein Angiography | 1 | 2014 | 1086 | 0.020 |
Why?
|
Thrombospondins | 1 | 2009 | 196 | 0.020 |
Why?
|
Propensity Score | 1 | 2016 | 1968 | 0.020 |
Why?
|
Aortography | 1 | 2010 | 422 | 0.020 |
Why?
|
Binding, Competitive | 1 | 2009 | 1142 | 0.020 |
Why?
|
Blood Coagulation | 1 | 2013 | 1161 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 1992 | 1246 | 0.020 |
Why?
|
Aortic Rupture | 1 | 2010 | 322 | 0.020 |
Why?
|
DNA | 2 | 1998 | 7214 | 0.020 |
Why?
|
Cell Membrane Structures | 1 | 2006 | 24 | 0.020 |
Why?
|
Cross Reactions | 1 | 1988 | 828 | 0.020 |
Why?
|
Cortactin | 1 | 2006 | 28 | 0.020 |
Why?
|
Recurrence | 1 | 2019 | 8512 | 0.020 |
Why?
|
Fluorescence Resonance Energy Transfer | 1 | 2009 | 414 | 0.020 |
Why?
|
Actin-Related Protein 2-3 Complex | 1 | 2006 | 61 | 0.020 |
Why?
|
Central Nervous System Diseases | 1 | 2010 | 521 | 0.020 |
Why?
|
Transcription, Genetic | 1 | 2000 | 7609 | 0.020 |
Why?
|
Child | 1 | 2014 | 80969 | 0.020 |
Why?
|
Immunoenzyme Techniques | 1 | 2009 | 1705 | 0.020 |
Why?
|
cdc42 GTP-Binding Protein | 1 | 2006 | 188 | 0.020 |
Why?
|
Multigene Family | 1 | 1988 | 1082 | 0.020 |
Why?
|
Minor Histocompatibility Antigens | 1 | 2006 | 304 | 0.020 |
Why?
|
Device Removal | 1 | 2010 | 643 | 0.010 |
Why?
|
Protein Kinases | 1 | 1992 | 1611 | 0.010 |
Why?
|
Blood Vessel Prosthesis | 1 | 2010 | 957 | 0.010 |
Why?
|
Prosthesis Failure | 1 | 2010 | 1209 | 0.010 |
Why?
|
Mutation | 2 | 2000 | 30266 | 0.010 |
Why?
|
Prosthesis-Related Infections | 1 | 2010 | 497 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2019 | 12563 | 0.010 |
Why?
|
Professional Competence | 1 | 2007 | 430 | 0.010 |
Why?
|
Liver Cirrhosis | 1 | 2015 | 1962 | 0.010 |
Why?
|
Blood Coagulation Disorders | 1 | 2007 | 350 | 0.010 |
Why?
|
Growth Substances | 1 | 2006 | 760 | 0.010 |
Why?
|
Gene Amplification | 1 | 1988 | 1099 | 0.010 |
Why?
|
Phosphotransferases (Alcohol Group Acceptor) | 1 | 2006 | 434 | 0.010 |
Why?
|
Adolescent | 2 | 2010 | 89247 | 0.010 |
Why?
|
Blood Proteins | 1 | 2009 | 1191 | 0.010 |
Why?
|
Echoencephalography | 1 | 2003 | 134 | 0.010 |
Why?
|
Melanoma, Experimental | 1 | 2006 | 559 | 0.010 |
Why?
|
Prosthesis Design | 1 | 2010 | 2126 | 0.010 |
Why?
|
Purpura | 1 | 2003 | 117 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2015 | 10778 | 0.010 |
Why?
|
Fibronectins | 1 | 2006 | 724 | 0.010 |
Why?
|
Monocytes | 1 | 1992 | 2603 | 0.010 |
Why?
|
Tissue Distribution | 1 | 2006 | 2299 | 0.010 |
Why?
|
Protein Isoforms | 1 | 2006 | 1714 | 0.010 |
Why?
|
Incidence | 1 | 2019 | 21545 | 0.010 |
Why?
|
Cytoskeletal Proteins | 1 | 2006 | 1328 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 1998 | 11934 | 0.010 |
Why?
|
Health Care Surveys | 1 | 2007 | 2437 | 0.010 |
Why?
|
Binding Sites | 1 | 2009 | 6023 | 0.010 |
Why?
|
Cell Adhesion Molecules | 1 | 2006 | 1614 | 0.010 |
Why?
|
Gene Silencing | 1 | 2006 | 1505 | 0.010 |
Why?
|
Reoperation | 1 | 2010 | 4342 | 0.010 |
Why?
|
Fetal Growth Retardation | 1 | 2003 | 590 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2006 | 3775 | 0.010 |
Why?
|
Cytomegalovirus | 1 | 2003 | 753 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2010 | 5323 | 0.010 |
Why?
|
Medical Errors | 1 | 2007 | 1262 | 0.010 |
Why?
|
Data Collection | 1 | 2007 | 3322 | 0.010 |
Why?
|
Neoplasm Invasiveness | 1 | 2006 | 3629 | 0.010 |
Why?
|
Child, Preschool | 1 | 2020 | 42684 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2015 | 7460 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2006 | 3433 | 0.010 |
Why?
|
Cell Membrane | 1 | 2006 | 3659 | 0.010 |
Why?
|
Protein Binding | 1 | 2009 | 9344 | 0.010 |
Why?
|
United States | 1 | 2003 | 73180 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 1992 | 10276 | 0.010 |
Why?
|
Placenta | 1 | 2003 | 1721 | 0.010 |
Why?
|
Cell Movement | 1 | 2006 | 5216 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2006 | 4940 | 0.010 |
Why?
|
Quality of Health Care | 1 | 2007 | 4338 | 0.010 |
Why?
|
Anticoagulants | 1 | 2007 | 4850 | 0.010 |
Why?
|
Prospective Studies | 1 | 2016 | 54950 | 0.010 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2003 | 2183 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2007 | 14795 | 0.010 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 1992 | 1057 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2006 | 19023 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 1992 | 474 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 1992 | 478 | 0.010 |
Why?
|
Risk Assessment | 1 | 2010 | 24330 | 0.000 |
Why?
|
DNA, Neoplasm | 1 | 1992 | 1748 | 0.000 |
Why?
|
Mice | 2 | 2006 | 82074 | 0.000 |
Why?
|
Infant, Newborn | 1 | 2003 | 26394 | 0.000 |
Why?
|
Amino Acid Sequence | 1 | 1992 | 13427 | 0.000 |
Why?
|
Cell Line | 1 | 1992 | 15603 | 0.000 |
Why?
|
Rats | 1 | 1992 | 23847 | 0.000 |
Why?
|